Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00919243Phase 4Completed
Phase 4, randomised trial of prednisone in heart failure (HF) and hyperuricemia (2 arms), sponsored by Hebei Medical University. Primary endpoint: Change from baseline in uric acid level at 4 weeks. Started Feb 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00919243.